医薬品API製造の世界市場レポート 2024

医薬品API製造の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.2%の年間複合成長率（CAGR）で2,790億3,000万米ドルに成長すると予想されます。予測期間の成長は、人口高齢化の増加、テクノロジーの急速な進歩、がん罹患率の増加、合併・買収の増加、新興国の潜在力の高さに起因すると考えられ、これらすべてが成長を促進します。予測期間の主な動向には、生産施設の拡大、人工知能（AI）の使用、より環境に優しいAPI製造への重点、投資の増加とQRコードラベルの使用への重点が含まれます。

高齢化人口の増加は、医薬品API製造市場の重要な推進力です。高齢化の進展に伴い、医薬品の需要も増加しています。 APIはこれらの医薬品において重要な役割を果たし、特定の疾患に対処するための専門薬として機能します。たとえば、2022年 10月に世界保健機関（WHO）が共有した記事では、高齢者の80%が2050年までに低所得国および中所得国に居住すると予測されていることが明らかになりました。高齢化人口は、世界の人口よりも速いペースで増加しています。過去と同様に、2020年には5歳未満よりも60歳以上の人口の方が多くなると予測されています。したがって、高齢化人口の増加が医薬品API製造市場を推進する重要な要因となります。

慢性疾患の急増は、将来医薬品API製造市場を牽引すると予想されます。慢性症状または慢性疾患は、長期間にわたって、多くの場合は人の一生にわたって持続する長期的な健康状態であり、通常は完全に治癒することはできません。医薬品の品質、有効性、安全性は、使用されるAPIに大きく依存します。 医薬品API製造は、慢性疾患の管理に不可欠な医薬品の製造において重要な役割を果たします。たとえば、2023年の国立医学図書館によると、50歳以上の米国成人のほぼ36%が2035年までに少なくとも1つの慢性疾患を患うと予測されており、この数は2050年までにほぼ48%に上昇すると予想されています。したがって、慢性疾患の増加は医薬品API製造市場の原動力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の医薬品API製造市場、治療分野別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 心血管障害
• 代謝障害
• 神経学的障害
• 腫瘍学
• 筋骨格系疾患
• NSAID
• その他の治療用途
• 世界の医薬品API製造市場、APIタイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 化学API
• 生物学API
• 世界の医薬品API製造市場、医薬品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 処方薬
• 市販薬（OTC）

第7章 地域および国の分析

• 世界の医薬品API製造市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の医薬品API製造市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品API製造市場の競合情勢
• 医薬品API製造市場の企業プロファイル
  • Pfizer Inc
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Dr. Reddy's Laboratories

第31章 その他の大手および革新的な企業

• BASF SE
• Sun Pharmaceutical Industries Ltd
• Novartis AG
• Lupin Ltd
• Cipla Inc.
• Arlak Biotech
• Healthkind Labs Pvt. Ltd
• SwisscheM Healthcare Pvt. Ltd
• Apikos Pharma
• Kolaz Biotech
• CStone Pharma
• CARsgen Therapeutics
• JW Therapeutics
• BeiGene
• Takeda Pharmaceuticals

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

The manufacturing of pharmaceutical active pharmaceutical ingredients (API) involves producing the active substances that impart the desired impact on the body for the treatment of a specific condition in pharmaceutical medicines. To create APIs, chemical components undergo processing. The active component of a biological drug is termed a bulk process intermediate.

pharmaceutical API manufacturing focuses on various therapy areas, including cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutic uses. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels. Chemical API and biological API are the primary types used in the production of innovative drugs, generic prescription drugs, and over-the-counter (OTC) drugs.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical active pharmaceutical ingredients (API) manufacturing market statistics, including pharmaceutical active pharmaceutical ingredients (API) manufacturing industry global market size, regional shares, competitors with a pharmaceutical active pharmaceutical ingredient (API) manufacturing market share, detailed pharmaceutical active pharmaceutical ingredients (API) manufacturing market segments, pharmaceutical active pharmaceutical ingredients (API) manufacturing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical active pharmaceutical ingredients (API) manufacturing industry. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical API manufacturing market size has grown strongly in recent years. It will grow from $206.95 billion in 2023 to $219.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%.The growth in the historical period can be attributed to an increase in research and development (R&D) expenditure in the pharmaceutical sector, a growing preference for outsourcing active pharmaceutical ingredients (APIs), a rise in the prevalence of chronic illnesses, increased healthcare expenditure, a growth in disposable income, an increase in patent expiration, and the implementation of government policies promoting API production.

The pharmaceutical API manufacturing market size is expected to see strong growth in the next few years. It will grow to $279.03 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing aging population, rapid advancements in technology, a rising prevalence of cancer, increasing mergers and acquisitions, and the high potential of emerging economies, all of which will drive growth. Major trends in the forecast period include a focus on expanding production facilities, the use of artificial intelligence (AI), emphasis on greener API manufacturing, and increased investments and focus on the use of QR code labeling.

The increase in the aging population is a significant driver of the pharmaceutical API manufacturing market. With the rise in the aging population, there is a corresponding increase in the demand for pharmaceutical drugs. APIs play a crucial role in these medicines, serving as specialty drugs to address specific diseases. For example, an article shared by the World Health Organization (WHO) in October 2022 revealed that 80% of senior citizens are projected to reside in low- and middle-income nations by 2050. The aging population is growing at a faster rate than in the past, with more individuals over the age of 60 than under five-year-olds projected for 2020. Therefore, the growth of the aging population is a key factor driving the pharmaceutical API manufacturing market.

The surge in chronic conditions is anticipated to drive the pharmaceutical API manufacturing market in the future. Chronic conditions, or chronic diseases, are long-term health conditions that persist for extended periods, often throughout a person's lifetime, and typically cannot be completely cured. The quality, effectiveness, and safety of medications depend significantly on the API used. pharmaceutical API manufacturing plays a crucial role in producing essential medications for managing chronic diseases. For instance, according to the National Library of Medicine in 2023, it is projected that nearly 36% of US adults aged 50 and older will have at least one chronic condition by 2035, with this number expected to rise to almost 48% by 2050. Therefore, the increase in chronic conditions is a driving force for the pharmaceutical API manufacturing market.

Many companies leverage modern technologies such as process control and powder handling to optimize the manufacturing of Active Pharmaceutical Ingredients (API). These technologies include advancements in Lyophilization, a freeze-drying process involving low-temperature dehydration by freezing the product, lowering pressure, and removing the formed ice. For example, Telstar, a company specializing in efficient integrated systems for pharmaceutical and manufacturing processes, introduced LyoGistics Zero-an automatic loading and unloading system for freeze dryers designed for hazardous products. The system utilizes a linear magnetic driving mechanism, eliminating racks and belts to reduce particle generation and enhance hygiene in API manufacturing. Additionally, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders to improve their mixing in a solution.

Key companies in the pharmaceutical API manufacturing market are dedicated to developing innovative solutions such as Apisolex to streamline manufacturing processes and minimize API loss. Apisolex, launched by Lubrizol Life Science (LLS) Health in March 2022, is a novel solubility-enhancing excipient technology addressing solubility challenges. It can significantly enhance solubility, support high drug loading, and optimize manufacturing efficiency by reducing API loss and ensuring efficient encapsulation.

In March 2021, Piramal Pharma Ltd., an India-based healthcare solutions company, acquired Hemmo Pharmaceuticals for $105.8 million. This strategic acquisition is poised to expand PPS's capacity to offer integrated services globally, providing access to the growing peptide API industry. The deal is expected to augment peptide API manufacturing and development capabilities. Hemmo Pharmaceuticals, based in India, specializes in the development and manufacturing of peptide APIs.

Major companies operating in the pharmaceutical API manufacturing market report are Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, BASF SE, Sun Pharmaceutical Industries Ltd., Novartis AG, Lupin Ltd., Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd., SwisscheM Healthcare Pvt. Ltd., Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc., Otsuka Pharmaceutical Co, Ltd., Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical, Sankyo, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Vectura Group, Roche Holding AG, Merck & Co, Boehringer Ingelheim, Zentiva, Microgen, Geropharm, Valenta, NovaMedica, Veropharm, Celon Pharma, SynBio, Generium, Skopinpharm, ALMEDIS, Biocad, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Mylan, BioVectra, Celgene Corporation, Kashiv Pharma, Cambrex, Eli Lilly and Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, AbbVie Inc., Hisun USA Inc., AMEGA Biotech, BioMarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, SAUDIBIO, Tabuk Pharmaceuticals, Bayer, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd., Aspen

North America was the largest region in the pharmaceutical API manufacturing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical API manufacturing market share during the forecast period. The regions covered in the pharmaceutical API manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical API manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market includes tablets, capsules, creams, and injectable sales. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical API Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical api manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical api manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical api manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Therapy Area: Cardiovascular Disorders; Metabolic Disorders; Neurological Disorders; Oncology; Musculoskeletal Disorders; Other Therapeutics Uses
• 2) By API Type: Chemical API; Biological API
• 3) By Drug Type: Prescription Drugs; Over-The-Counter (OTC) Drugs
• Companies Mentioned: Pfizer Inc; Sanofi S.A; Teva Pharmaceutical Industries Ltd.; Aurobindo Pharma; Dr. Reddy's Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical API Manufacturing Market Characteristics

3. Pharmaceutical API Manufacturing Market Trends And Strategies

4. Pharmaceutical API Manufacturing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical API Manufacturing Market Size and Growth

• 5.1. Global Pharmaceutical API Manufacturing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pharmaceutical API Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pharmaceutical API Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical API Manufacturing Market Segmentation

• 6.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cardiovascular disorders
• Metabolic disorders
• Neurological disorders
• Oncology
• Musculoskeletal disorders
• NSAIDs
• Other therapeutics uses
• 6.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemical API
• Biological API
• 6.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Prescription Drugs
• Over-the-counter (OTC) Drugs

7. Pharmaceutical API Manufacturing Market Regional And Country Analysis

• 7.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical API Manufacturing Market

• 8.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical API Manufacturing Market

• 9.1. China Pharmaceutical API Manufacturing Market Overview
• 9.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical API Manufacturing Market

• 10.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical API Manufacturing Market

• 11.1. Japan Pharmaceutical API Manufacturing Market Overview
• 11.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical API Manufacturing Market

• 12.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical API Manufacturing Market

• 13.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical API Manufacturing Market

• 14.1. South Korea Pharmaceutical API Manufacturing Market Overview
• 14.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical API Manufacturing Market

• 15.1. Western Europe Pharmaceutical API Manufacturing Market Overview
• 15.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical API Manufacturing Market

• 16.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical API Manufacturing Market

• 17.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical API Manufacturing Market

• 18.1. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical API Manufacturing Market

• 19.1. Italy Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical API Manufacturing Market

• 20.1. Spain Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical API Manufacturing Market

• 21.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview
• 21.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical API Manufacturing Market

• 22.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical API Manufacturing Market

• 23.1. North America Pharmaceutical API Manufacturing Market Overview
• 23.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical API Manufacturing Market

• 24.1. USA Pharmaceutical API Manufacturing Market Overview
• 24.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical API Manufacturing Market

• 25.1. Canada Pharmaceutical API Manufacturing Market Overview
• 25.2. Canada Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical API Manufacturing Market

• 26.1. South America Pharmaceutical API Manufacturing Market Overview
• 26.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical API Manufacturing Market

• 27.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical API Manufacturing Market

• 28.1. Middle East Pharmaceutical API Manufacturing Market Overview
• 28.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical API Manufacturing Market

• 29.1. Africa Pharmaceutical API Manufacturing Market Overview
• 29.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical API Manufacturing Market Competitive Landscape
• 30.2. Pharmaceutical API Manufacturing Market Company Profiles
  • 30.2.1. Pfizer Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Sanofi S.A
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Teva Pharmaceutical Industries Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Aurobindo Pharma
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Dr. Reddy's Laboratories
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pharmaceutical API Manufacturing Market Other Major And Innovative Companies

• 31.1. BASF SE
• 31.2. Sun Pharmaceutical Industries Ltd
• 31.3. Novartis AG
• 31.4. Lupin Ltd
• 31.5. Cipla Inc.
• 31.6. Arlak Biotech
• 31.7. Healthkind Labs Pvt. Ltd
• 31.8. SwisscheM Healthcare Pvt. Ltd
• 31.9. Apikos Pharma
• 31.10. Kolaz Biotech
• 31.11. CStone Pharma
• 31.12. CARsgen Therapeutics
• 31.13. JW Therapeutics
• 31.14. BeiGene
• 31.15. Takeda Pharmaceuticals

32. Global Pharmaceutical API Manufacturing Market Competitive Benchmarking

33. Global Pharmaceutical API Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

35. Pharmaceutical API Manufacturing Market Future Outlook and Potential Analysis

• 35.1 Pharmaceutical API Manufacturing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical API Manufacturing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical API Manufacturing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer